论TPP协议知识产权章节中的药品数据保护条款

The Study on the “Pharmaceutical Data Protection” Clause of Intellectual Property Charter of TPP Agreement

后TRIPS时代,为了推行高标准的知识产权保护,发达国家开始绕开国际组织,转而采用签署双边或者多边自由贸易协定(FTA)的方式。"跨太平洋伙伴关系协议"(TPP)作为其中的一员,代表着当前知识产权国际保护的最新前沿。其中所规定的"药品数据保护"条款是以美国为代表的发达国家推行高标准知识产权保护的典例。"药品数据保护"条款过于严苛的保护标准将不可避免地损害社会公共利益,甚至引发公共健康危机。

In Post-TRIPS era, in order to implement high standards of intellectual property protection, developed countries have started to bypass the International Organizations and have turned to sign bilateral or multilateral Free Trade Agreement(FTA). As one of the FTAs, 'Trans-Pacific Partnership Agreement'(TPP) represents the latest frontier of International Intellectual Property Protection. 'Pharmaceutical Data Protection ' clause, which is provided in the TPP Agreement, is regarded as the representative of the developed countries who are devote to pursue a high standard of intellectual property protection. The 'Pharmaceutical Data Protection' clause is too stringent.It will inevitably harm the public interests and even trigger the public health crisis.